Vu V T, Møller M E, Grantham P H, Wirth P J, Thorgeirsson S S
Carcinogenesis. 1985 Jan;6(1):45-52. doi: 10.1093/carcin/6.1.45.
N-hydroxy-2-acetylaminofluorene (N-OH-AAF) and N-acetoxy-2-acetylaminofluorene (N-OAc-AAF) have previously been shown to induce dose-dependent DNA strand breaks in primary hepatocytes from mice and rats. In an attempt to determine the relationship between the extent of DNA strand breaks and the formation of specific DNA-carcinogen bound adducts in murine liver, the capability of N-OH-AAF and N-OAc-AAF to induce both DNA single strand breaks and adduct formation in in vivo and in primary hepatocytes was measured. N-OH-AAF induced a low level of DNA damage in F344 rats (10 mg/kg, i.p.) and in B6 mice (40 mg/kg, i.p.) 4 h after treatment. The DNA adducts identified in vivo were N-(guanin-8-yl)-2-acetylaminofluorene (Gua-C8-AAF) 55% versus 11%, N-(guanin-8-yl)-2-aminofluorene (Gua-C8-AF) 34% versus 67% and 3-(guanin-N2-yl)-2-acetylaminofluorene (Gua-N2-AAF) 11% versus 10%, respectively, for rat and mouse liver. An additional unknown adduct (12%) was detected in mouse liver. Dose dependent DNA binding and formation of individual DNA adducts were observed in rat and mouse primary hepatocytes following 1 h exposure to [ring-3H]-N-OH-AAF (0.1-20 microM) and [ring-3H]-N-OAc-AAF (5-20 microM). The patterns of DNA adducts in mouse and rat primary hepatocytes exposed to N-OH-AAF and N-OAc-AF were similar to those obtained in liver following in vivo treatment with N-OH-AAF. The deacetylase inhibitor, paraoxon (10(-4) M) completely inhibited DNA damage induced by N-OH-AAF in mouse and partially in rat hepatocytes while DNA damage caused by N-OAc-AAF was only partially inhibited by paraoxon (10(-4) M) in both species. Parallel experiments showed that paraoxon, at low concentration (10(-6) M), did not alter either the level of DNA binding or the pattern of adduct formation in rat hepatocytes treated with N-OH-AAF (20 microM). However, at 10(-4) M paraoxon partially blocked DNA binding (60%) and the formation of Gua-C8-AAF (95%) and Gua-N2-AAF (80%) while Gua-C8-AF was increased two-fold. In mouse hepatocytes paraoxon pretreatment (10(-4) M) inhibited the formation of Gua-C8-AF by 70% following exposure to N-OH-AAF (20 microM). Gua-C8-AAF and Gua-N2-AAF were also inhibited but only at 10(-4) M paraoxon.(ABSTRACT TRUNCATED AT 400 WORDS)
N-羟基-2-乙酰氨基芴(N-OH-AAF)和N-乙酰氧基-2-乙酰氨基芴(N-OAc-AAF)先前已被证明可在小鼠和大鼠的原代肝细胞中诱导剂量依赖性DNA链断裂。为了确定DNA链断裂程度与小鼠肝脏中特定DNA-致癌物结合加合物形成之间的关系,测量了N-OH-AAF和N-OAc-AAF在体内和原代肝细胞中诱导DNA单链断裂和加合物形成的能力。N-OH-AAF在处理后4小时,在F344大鼠(10毫克/千克,腹腔注射)和B6小鼠(40毫克/千克,腹腔注射)中诱导了低水平的DNA损伤。在体内鉴定出的DNA加合物,对于大鼠和小鼠肝脏,N-(鸟嘌呤-8-基)-2-乙酰氨基芴(Gua-C8-AAF)分别为55%对11%,N-(鸟嘌呤-8-基)-2-氨基芴(Gua-C8-AF)为34%对67%,3-(鸟嘌呤-N2-基)-2-乙酰氨基芴(Gua-N2-AAF)为11%对10%。在小鼠肝脏中还检测到一种额外的未知加合物(12%)。在大鼠和小鼠原代肝细胞中,用[环-3H]-N-OH-AAF(0.1-20微摩尔)和[环-3H]-N-OAc-AAF(5-20微摩尔)处理1小时后,观察到剂量依赖性DNA结合和单个DNA加合物的形成。暴露于N-OH-AAF和N-OAc-AF的小鼠和大鼠原代肝细胞中的DNA加合物模式与用N-OH-AAF进行体内处理后在肝脏中获得的模式相似。脱乙酰酶抑制剂对氧磷(10^-4摩尔)完全抑制了N-OH-AAF在小鼠肝细胞中诱导的DNA损伤,并部分抑制了大鼠肝细胞中的损伤,而N-OAc-AAF在两个物种中引起的DNA损伤仅被对氧磷(10^-4摩尔)部分抑制。平行实验表明,低浓度(10^-6摩尔)的对氧磷不会改变用N-OH-AAF(20微摩尔)处理的大鼠肝细胞中的DNA结合水平或加合物形成模式。然而,在10^-4摩尔时,对氧磷部分阻断了DNA结合(60%)以及Gua-C8-AAF(95%)和Gua-N2-AAF(80%)的形成,而Gua-C8-AF增加了两倍。在小鼠肝细胞中,对氧磷预处理(10^-4摩尔)在暴露于N-OH-AAF(20微摩尔)后抑制了70%的Gua-C8-AF形成。Gua-C8-AAF和Gua-N2-AAF也受到抑制,但仅在10^-4摩尔对氧磷时。(摘要截短至400字)